InvestorsHub Logo
Followers 87
Posts 6707
Boards Moderated 1
Alias Born 09/18/2009

Re: daemon57 post# 141557

Tuesday, 01/19/2021 8:37:02 PM

Tuesday, January 19, 2021 8:37:02 PM

Post# of 233218
Actually, the BEST Covid stocks I have are IPIX and RLFTF, both up almost 43% from my purchase price. However, they are both at levels where I expected resistance, so I sold some RLFTF at $0.44 today. CYDY is up 3% from my last purchase, and HGEN is now up only 21.7%. Until now, all three of those stocks, excluding CYDY, have been up in the 35% range. HGEN is already recovering following the after hours drop, but it didn't get low enough to fill a bid I put in tonight.

I don't view the HGEN news as unpleasant. I expected to see a similar endpoint change announcement here. Here's a good discussion on that topic.

"Of the nearly 8,000 patients who tested positive for COVID-19 and were treated at Mayo Clinic from March 1 to July 31, 897 were hospitalized, 354 in the ICU. Nearly 78% of hospitalized patients received at least one therapy. The research also found lower mortality rates than compared to other hospitals, at 1.1%.

During the same time period in the U.S., 3% of patients died,” Badley said."


The above is from Mayo Clinic's treatment record. For more information, see below.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161033370

Lower mortality is going to be a tough endpoint for leronlimab to show statistically significant improvement over standard of care. But I would be happy to add more CYDY if the price drops.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News